Stephen W. Schondelmeyer BS, PharmD, MPA, PhD, FAPhA

Dr. Schondelmeyer is a professor of pharmaceutical economics at the University of Minnesota’s College of Pharmacy. He holds the Century Mortar Club Endowed Chair in Pharmaceutical Management & Economics and has served for 24 years as Department Head for Pharmaceutical Care & Health Systems. He received his BS in pharmacy from the University of Missouri-Kansas City, PharmD and ASHP Residency at University of Kentucky, and Masters in Public Administration and PhD in Pharmaceutical Administration at The Ohio State University along with a National Endowment for Humanities Fellowship in History of Medicine.

He has conducted economic and public policy research on roles of pharmacists and pharmaceuticals in society for over 50 years. In 1991 he founded, and continues to direct, the PRIME Institute which is an independent research organization at the University of Minnesota. His research has influenced many key policy areas including prescription drug access and affordability, drug price competition, pharmacists’ compensation and workforce trends, and policy to reduce drug shortages and to improve drug supply resilience. He has conducted research for CMS, GAO, FDA, the Congressional Office of Technology Assessment (OTA), the US Senate Special Committee on Aging, AARP, the pharmaceutical industry, and pharmacy associations.

Dr. Schondelmeyer has effectively presented to policymakers at state, national and international levels. He has testified before the U.S. Congress more than 25 times, to more than 20 state legislatures, and as an expert witness in more than 85 lawsuits to increase availability and affordability of prescription drugs. He was appointed to the Prescription Drug Payment Review Commission to advise Congress on the outpatient drug program of the Medicare Catastrophic Coverage Act. His work is widely recognized as an objective and credible source of policy analysis and has become well-known not only to those within pharmacy, but also to those outside of the profession (i.e., policymakers, public media, other health professions, PBMs and insurers, the pharmaceutical industry, consumer advocacy groups, and others).

Dr. Schondelmeyer's education, experience, and background have provided him with a unique understanding of the complex and technical issues leading to dramatic changes in the pharmaceutical marketplace. His work experience has encompassed activities in practice, academia, professional associations, and state and federal government. He has received a number of national honors and awards including APhA’s Tyler Prize for Stimulation of Research, the APRS Research Achievement Award in Pharmaceutical Sciences, and the Hubert H. Humphrey Award